Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-24-000016

Chief Scientific Officer gave up 2,255 shares (to pay taxes)

  • Chief Scientific Officer acquired 27,300 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Fisher Stewart · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-13 Shares withheld for taxes : show line 1 in the form −2,255 $6.53 $14,725 101,821 D
2024-02-14 Grant or award : show line 2 in the form +27,300 129,121 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-14 Grant or award : show line 3 in the form Stock Option (Right to Buy) +122,800 122,800 D
Loading xslF345X05/wk-form4_1708034642.xml…